GBp 3.75
(4.17%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -3.25 Million | -828.93 Thousand | 1.48 Million | -172.57 Thousand | 1.89 Million | -4.57 Million |
Net Income | -4.67 Million | -2.79 Million | 5.89 Million | -3.58 Million | -136.62 Thousand | - |
Depreciation & Amortization | 843.23 Thousand | 632.93 Thousand | 396.42 Thousand | 333.18 Thousand | 313.65 Thousand | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 321.59 Thousand | 1.13 Million | -2.74 Million | 453.74 Thousand | 1.86 Million | - |
Other non-cash items | 191.25 Thousand | 200.73 Thousand | -2.06 Million | 2.62 Million | -148.52 Thousand | - |
Investing Cash Flow | -1.45 Million | -44.24 Thousand | -783.25 Thousand | -181.81 Thousand | -500.05 Thousand | -1.02 Million |
Investments in PPE | -3.94 Million | -1.43 Million | -783.25 Thousand | -389.82 Thousand | -636.8 Thousand | -1.11 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | 165.36 Thousand | - | - |
Other Investing Activities | -820.21 Thousand | 1.39 Million | - | 42.64 Thousand | 136.75 Thousand | 92.28 Thousand |
Financing Cash Flow | 4.86 Million | 775.84 Thousand | 285.47 Thousand | 1845.00 | -571.78 Thousand | 5.77 Million |
Debt repayment | -1.47 Million | -1.34 Million | -677.37 Thousand | -628.13 Thousand | -5.2 Million | -100.25 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 3.47 Million | 999.99 Thousand | -1.22 Million | - | - | - |
Other Financing Activities | 14.16 Thousand | 1.11 Million | 2.19 Million | 629.97 Thousand | 4.62 Million | 5.87 Million |
Accounts receivables | 406.1 Thousand | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | 673.00 | 30.7 Thousand | -159.79 Thousand | 23.8 Thousand | 37.69 Thousand | - |
Other working capital | -85.18 Thousand | 1.1 Million | -2.58 Million | 429.93 Thousand | 1.83 Million | - |
Cash at beginning of period | 35.56 Thousand | 152.68 Thousand | 521.32 Thousand | 1.01 Million | 185.82 Thousand | 5715.00 |
Cash at end of period | 186.88 Thousand | 35.56 Thousand | 1.52 Million | 521.32 Thousand | 1.01 Million | 185.82 Thousand |
Capital Expenditure | -3.94 Million | -1.43 Million | -783.25 Thousand | -389.82 Thousand | -636.8 Thousand | -1.11 Million |
Effect of forex changes on cash | -7323.00 | -19.78 Thousand | 12.73 Thousand | -137.46 Thousand | - | - |
Net cash flow / Change in cash | 151.31 Thousand | -117.12 Thousand | 999.27 Thousand | -490 Thousand | 825.51 Thousand | 180.1 Thousand |
Free Cash Flow | -7.2 Million | -2.26 Million | 701.06 Thousand | -562.4 Thousand | 1.26 Million | -5.69 Million |
Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2021 FY |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1.59 Million | -2.01 Million | -4.67 Million | -2.05 Million | -2.79 Million | 5.89 Million |
Depreciation & Amortization | 362.11 Thousand | 345.71 Thousand | 843.23 Thousand | 387.96 Thousand | 632.93 Thousand | 396.42 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -360.26 Thousand | 657.51 Thousand | 321.59 Thousand | -379.9 Thousand | 1.13 Million | -2.74 Million |
Other non-cash items | -49.96 Thousand | 250.33 Thousand | 191.25 Thousand | 1.19 Million | 200.73 Thousand | -2.06 Million |
Investing Cash Flow | -213.38 Thousand | -332.78 Thousand | -1.45 Million | -920.59 Thousand | -44.24 Thousand | -783.25 Thousand |
Investments in PPE | -26.54 Thousand | -2.24 Million | -3.94 Million | -1.16 Million | -1.43 Million | -783.25 Thousand |
Acquisitions | - | 1022.93 | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 1.05 Million | 1.91 Million | - | 241.19 Thousand | 1.39 Million | - |
Financing Cash Flow | 1.77 Million | 1.07 Million | 4.86 Million | 3.12 Million | 775.84 Thousand | 285.47 Thousand |
Debt repayment | -341.83 Thousand | -1.26 Million | -1.47 Million | -11.4 Thousand | -1.34 Million | -677.37 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 1.28 Million | -45.28 Thousand | 3.47 Million | 3.04 Million | 999.99 Thousand | -1.22 Million |
Other Financing Activities | 141.74 Thousand | -101.6 Thousand | 14.16 Thousand | 113.83 Thousand | 1.11 Million | 2.19 Million |
Accounts receivables | -276.9 Thousand | 261.44 Thousand | - | 89.11 Thousand | - | - |
Accounts payables | -118.56 Thousand | 426.53 Thousand | - | -500.06 Thousand | - | - |
Inventory | 35.2 Thousand | -30.46 Thousand | 673.00 | 31.04 Thousand | 30.7 Thousand | -159.79 Thousand |
Other working capital | - | - | - | 2.00 | 1.1 Million | -2.58 Million |
Cash at beginning of period | 161.93 Thousand | 218.23 Thousand | 35.56 Thousand | 22.94 Thousand | 152.68 Thousand | 521.32 Thousand |
Cash at end of period | 78.17 Thousand | 161.93 Thousand | 186.88 Thousand | 218.23 Thousand | 35.56 Thousand | 1.52 Million |
Capital Expenditure | -26.54 Thousand | -2.24 Million | -3.94 Million | -1.16 Million | -1.43 Million | -783.25 Thousand |
Effect of forex changes on cash | - | - | -7323.00 | - | -19.78 Thousand | 12.73 Thousand |
Net cash flow / Change in cash | -83.76 Thousand | -56.29 Thousand | 151.31 Thousand | 195.28 Thousand | -117.12 Thousand | 999.27 Thousand |
Free Cash Flow | -1.67 Million | -3.04 Million | -7.2 Million | -3.17 Million | -2.26 Million | 701.06 Thousand |
BEATW
0GMG
CRCL
NATCOPHARM
BMET
SXTY